Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management
Premature ovarian failure (POF) is an insidious cause of female infertility and a devastating condition for women. POF also has a strong familial and heterogeneous genetic background. Management of POF is complicated by the variable etiology and presentation, which are generally characterized by abn...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1194865/full |
| _version_ | 1797813403204452352 |
|---|---|
| author | Xu Yang Lin Yang |
| author_facet | Xu Yang Lin Yang |
| author_sort | Xu Yang |
| collection | DOAJ |
| description | Premature ovarian failure (POF) is an insidious cause of female infertility and a devastating condition for women. POF also has a strong familial and heterogeneous genetic background. Management of POF is complicated by the variable etiology and presentation, which are generally characterized by abnormal hormone levels, gene instability and ovarian dysgenesis. To date, abnormal regulation associated with POF has been found in a small number of genes, including autosomal and sex chromosomal genes in folliculogenesis, granulosa cells, and oocytes. Due to the complex genomic contributions, ascertaining the exact causative mechanisms has been challenging in POF, and many pathogenic genomic characteristics have yet to be elucidated. However, emerging research has provided new insights into genomic variation in POF as well as novel etiological factors, pathogenic mechanisms and therapeutic intervention approaches. Meanwhile, scattered studies of transcriptional regulation revealed that ovarian cell function also depends on specific biomarker gene expression, which can influence protein activities, thus causing POF. In this review, we summarized the latest research and issues related to the genomic basis for POF and focused on insights gained from their biological effects and pathogenic mechanisms in POF. The present integrated studies of genomic variants, gene expression and related protein abnormalities were structured to establish the role of etiological genes associated with POF. In addition, we describe the design of some ongoing clinical trials that may suggest safe, feasible and effective approaches to improve the diagnosis and therapy of POF, such as Filgrastim, goserelin, resveratrol, natural plant antitoxin, Kuntai capsule et al. Understanding the candidate genomic characteristics in POF is beneficial for the early diagnosis of POF and provides appropriate methods for prevention and drug treatment. Additional efforts to clarify the POF genetic background are necessary and are beneficial for researchers and clinicians regarding genetic counseling and clinical practice. Taken together, recent genomic explorations have shown great potential to elucidate POF management in women and are stepping from the bench to the bedside. |
| first_indexed | 2024-03-13T07:52:26Z |
| format | Article |
| id | doaj.art-d199a05ef806485998106fa6f8737b36 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-13T07:52:26Z |
| publishDate | 2023-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-d199a05ef806485998106fa6f8737b362023-06-02T14:04:12ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-06-011010.3389/fmed.2023.11948651194865Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and managementXu Yang0Lin Yang1Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, ChinaDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, ChinaPremature ovarian failure (POF) is an insidious cause of female infertility and a devastating condition for women. POF also has a strong familial and heterogeneous genetic background. Management of POF is complicated by the variable etiology and presentation, which are generally characterized by abnormal hormone levels, gene instability and ovarian dysgenesis. To date, abnormal regulation associated with POF has been found in a small number of genes, including autosomal and sex chromosomal genes in folliculogenesis, granulosa cells, and oocytes. Due to the complex genomic contributions, ascertaining the exact causative mechanisms has been challenging in POF, and many pathogenic genomic characteristics have yet to be elucidated. However, emerging research has provided new insights into genomic variation in POF as well as novel etiological factors, pathogenic mechanisms and therapeutic intervention approaches. Meanwhile, scattered studies of transcriptional regulation revealed that ovarian cell function also depends on specific biomarker gene expression, which can influence protein activities, thus causing POF. In this review, we summarized the latest research and issues related to the genomic basis for POF and focused on insights gained from their biological effects and pathogenic mechanisms in POF. The present integrated studies of genomic variants, gene expression and related protein abnormalities were structured to establish the role of etiological genes associated with POF. In addition, we describe the design of some ongoing clinical trials that may suggest safe, feasible and effective approaches to improve the diagnosis and therapy of POF, such as Filgrastim, goserelin, resveratrol, natural plant antitoxin, Kuntai capsule et al. Understanding the candidate genomic characteristics in POF is beneficial for the early diagnosis of POF and provides appropriate methods for prevention and drug treatment. Additional efforts to clarify the POF genetic background are necessary and are beneficial for researchers and clinicians regarding genetic counseling and clinical practice. Taken together, recent genomic explorations have shown great potential to elucidate POF management in women and are stepping from the bench to the bedside.https://www.frontiersin.org/articles/10.3389/fmed.2023.1194865/fullpremature ovarian failure (POF)infertilitygenomic variantstreatmentclinical trials |
| spellingShingle | Xu Yang Lin Yang Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management Frontiers in Medicine premature ovarian failure (POF) infertility genomic variants treatment clinical trials |
| title | Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management |
| title_full | Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management |
| title_fullStr | Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management |
| title_full_unstemmed | Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management |
| title_short | Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management |
| title_sort | current understanding of the genomic abnormities in premature ovarian failure chance for early diagnosis and management |
| topic | premature ovarian failure (POF) infertility genomic variants treatment clinical trials |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1194865/full |
| work_keys_str_mv | AT xuyang currentunderstandingofthegenomicabnormitiesinprematureovarianfailurechanceforearlydiagnosisandmanagement AT linyang currentunderstandingofthegenomicabnormitiesinprematureovarianfailurechanceforearlydiagnosisandmanagement |